ISBD would like to thank their Supporting Corporations for 2023
The support received from these Corporations allows the ISBD to continue to offer valuable resources for professionals, those with lived experience and their carers, as well as to further initiatives to advance the diagnosis and treatment of bipolar disorders.
Gold Supporting Corporations:
Otsuka
Lundbeck
Bronze Supporting Corporations:
Alkermes
Intra-Cellular Therapies, Inc.
NRx Pharmaceuticals
Additional Supporting Corporations:
Janssen Neuroscience (Pharmaceutical Companies of Johnson & Johnson)